XORTX Therapeutics
XRTX2.0600.49% ( +0.010 )
XORTX Therapeutics (XRTX)
XORTX Therapeutics Inc., a late-stage clinical pharmaceutical company, engages in the development and commercialization of therapies to treat hyperuricemia rela...
- Open
- 2.055
- High
- 2.090
- Low
- 2.010
- Prev. Close
- 2.050
- Volume
- 25.43K
- Turnover
- 51.37K
- Avg Price
- 2.020
- Bid/Ask Ratio
- --
- Amplitude
- 3.90%
- 52wk High
- 7.050
- Volume Ratio
- 1.24
- Turnover Ratio
- 1.86%
XORTX Therapeutics Analyst Rating
View MoreForecast & Rating
Sep 18, 2025Price forecast
$70.153305.42%
Forecast & RatingStrong buy
1analysts
- Strong buy100.00%
- Buy0.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
News
- benzinga_article · Jun 30 at 07:05 AM
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
- StockTitan · Jun 12 at 08:00 AM
XORTX Announces Election to Voluntary Delist from the TSX Venture Exchange | XRTX Stock News
- Price Alert · Apr 27 at 03:00 AM
U.S. Stock Market Movement Update: The biotechnology sector rebounded strongly, with Intellia rising 31.33% to lead the gains, while Cheetah fell 20%, attracting attention
- Price Alert · Apr 27 at 02:22 AM
U.S. stock night market volatility: XORTX Therapeutics fell 7.59% in after-hours trading, market volatility intensified, and capital flow has drawn attention
- Price Alert · Apr 22 at 11:00 PM
U.S. Stock Market Movement Update: Tech stocks are active, Triller rises nearly 17%, Tevogen Bio falls over 15%
- Price Alert · Apr 22 at 10:00 PM
U.S. stock market movement report: Technology stocks are active, Xiao I rises 18.46%, Texas Instruments rises 10.66%; ServiceNow falls 13.12%
